Fenbenco 222 – Fenbendazole 222 mg Tablets
Fenbenco 222 is available as uncoated tablets, with each tablet containing 222 mg of Fenbendazole IP. The displayed packaging contains 10 × 10 tablets and identifies the product as a prescription medicine. The product should be used in accordance with the directions and warnings printed on the original packaging.
Product Composition
Fenbendazole IP 222 mg
As stated on the packaging, each uncoated tablet provides 222 mg of Fenbendazole. The tablet also includes other excipients as needed for the formulation.
Product Information
Fenbenco 222 is supplied in tablet form and is intended to be used according to the directions and warnings on the original package.
The packaging clearly states that a physician should determine the dosage. Do not decide on a dose, treatment length, or reason for use based solely on information found on the internet.
Directions for Use
Use Fenbenco 222 strictly as directed on the product packaging and in consultation with a qualified healthcare professional.
Do not increase the dose, repeat the course of treatment, or use the product for a different purpose without proper professional guidance.
Important Safety Information
Before using any prescription medication, discuss any relevant medical conditions, allergies, and other medications or healthcare products with a qualified healthcare professional.
If you experience any unexpected or serious reaction, seek immediate medical attention. Information provided on an e-commerce product page is not meant to diagnose a condition or develop an individualized treatment plan.
Regulatory and Use Notice
The regulatory uses of Fenbendazole can vary by country and specific product. The presence of Fenbendazole in this product should not be considered as approval for all potential uses or indications.
This page does not claim that the U.S. FDA approves Fenbenco 222 for human use. It also does not promote Fenbendazole as a treatment for cancer or other unapproved conditions.
Storage and Handling
The package instructions advise users to protect the tablets from light and moisture and to store them at a temperature not exceeding 30°C. Keep the medicine out of reach of children and retain it in its original packaging.
Manufacturer Information
The displayed packaging identifies Astonea Labs Limited as the manufacturer.
Important Notice
This page provides general product information based on the packaging details and should not be used as a substitute for professional medical advice, diagnosis, treatment, or official product documentation. Regulatory status and permitted uses may vary by country. Always review the original packaging and consult an appropriate healthcare professional before using the product.
Reviews
Write Your Own Review